Pharmacoepidemiology and Drug Safety

© John Wiley & Sons, Ltd.

Cover image for Pharmacoepidemiology and Drug Safety

June 2003

Volume 12, Issue 4

Pages 269–356

  1. Editorials

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. Journal's policy regarding conflict of interest (pages 269–270)

      Ronald Mann and Brian L. Strom

      Article first published online: 15 MAY 2003 | DOI: 10.1002/pds.847

  2. Original Reports

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. Biases affecting the proportional reporting ratio (PRR) in spontaneous reports pharmacovigilance databases: the example of sertindole (pages 271–281)

      Nicholas Moore, Gillian Hall, Miriam Sturkenboom, Ron Mann, Rajaa Lagnaoui and Bernard Begaud

      Article first published online: 22 APR 2003 | DOI: 10.1002/pds.848

  3. Commentaries

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. Dealing with uncertainty in drug safety: lessons for the future from sertindole (pages 283–287)

      Patrick Waller

      Article first published online: 15 MAY 2003 | DOI: 10.1002/pds.849

  4. Responses

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. Response to Dr Patrick Waller's comment (pages 289–290)

      Nicholas Moore, Ron Mann, Gillian Hall and Miriam Sturkenboom

      Article first published online: 15 MAY 2003 | DOI: 10.1002/pds.850

  5. Editorials

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. ‘Dear doctor…’—Evaluating the impact of risk communication efforts (pages 291–293)

      Paul J. Seligman

      Article first published online: 15 MAY 2003 | DOI: 10.1002/pds.829

  6. Original Reports

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. Impact of cisapride label changes on codispensing of contraindicated medications (pages 295–301)

      Jeff Jianfei Guo, Suellen Curkendall, Judith K. Jones, Daniel Fife, Earl Goehring and Dewei She

      Article first published online: 26 MAR 2003 | DOI: 10.1002/pds.830

  7. Editorials

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. The liver and statin drug therapy: uncertain navigation in the sea of risk-benefit (pages 303–306)

      Stephen H. Caldwell, Jeffrey S. Zaidman and Elizabeth E. Hespenheide

      Article first published online: 15 MAY 2003 | DOI: 10.1002/pds.833

  8. Original Reports

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. Liver function testing in patients on HMG-CoA reductase inhibitors (pages 307–313)

      Susan E. Andrade, James G. Donahue, K. Arnold Chan, Douglas J. Watson and Richard Platt

      Article first published online: 26 MAR 2003 | DOI: 10.1002/pds.832

    2. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III) (pages 315–326)

      Ryne Paulose-Ram, Rosemarie Hirsch, Charles Dillon, Katalin Losonczy, Michael Cooper and Yechiam Ostchega

      Article first published online: 26 SEP 2002 | DOI: 10.1002/pds.755

  9. Research Articles

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000 (pages 327–334)

      Lisa G. Pont, Miriam C. J. M. Sturkenboom, Wiek H. van Gilst, Petra Denig and Flora M. Haaijer-Ruskamp

      Article first published online: 3 FEB 2003 | DOI: 10.1002/pds.809

  10. ISPE Commentaries

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. The Brighton Collaboration: enhancing comparability of vaccine safety data (pages 335–340)

      Katrin S. Kohl, Jan Bonhoeffer, Robert Chen, Philippe Duclos, Harald Heijbel, Ulrich Heininger and Elisabeth Loupi

      Article first published online: 6 MAY 2003 | DOI: 10.1002/pds.851

  11. Current Awareness

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Commentaries
    5. Responses
    6. Editorials
    7. Original Reports
    8. Editorials
    9. Original Reports
    10. Research Articles
    11. ISPE Commentaries
    12. Current Awareness
    1. Current Awareness: Pharmacoepidemiology and Drug Safety (pages 341–356)

      Article first published online: 15 MAY 2003 | DOI: 10.1002/pds.790

SEARCH

SEARCH BY CITATION